{"id":"W3119708965","doi":"10.1016/j.eururo.2020.12.029","title":"Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Pazopanib; Nephrectomy; Renal cell carcinoma; Placebo; Adjuvant; Oncology; Urology; Internal medicine; Kidney cancer; Surgery; Kidney; Sunitinib; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002893798,0.001262552,0.002217533,0.0002719829,0.000220078,0.0007666996,0.0004484872,0.0008573266,0.002185215],"category_scores_gemma":[0.001691676,0.0002941332,0.003532098,0.0002852926,0.0005413866,0.0007609135,0.0003792958,0.002925474,0.0003859228],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004963188,"about_ca_system_score_gemma":0.0006993336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003380167,"about_ca_topic_score_gemma":0.001058848,"domain_scores_codex":[0.9991955,0.0004901131,0.00004476133,0.0001062008,0.00006874256,0.00009460841],"domain_scores_gemma":[0.9992396,0.0002332634,0.0002211997,0.00007377723,0.00004861811,0.0001835609],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9601158,0.003071349,0.002247883,0.0008803541,0.003697028,0.0000606096,0.00005792644,0.001314677,0.004543692,0.0001680823,0.00154639,0.02229609],"study_design_scores_gemma":[0.7318212,0.2365538,0.01919309,0.0001378182,0.004613007,0.000198801,0.00004972368,0.002072935,0.001562477,0.0009210217,0.002830171,0.00004593569],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9811364,0.01164424,0.0009575992,0.0008056983,0.0004278056,0.0009094754,0.001595718,0.00008855276,0.002434453],"genre_scores_gemma":[0.989837,0.0033395,0.0008004362,0.0007966501,0.0004149586,0.001165989,0.002163496,0.00002301543,0.001458977],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002893798,"threshold_uncertainty_score":0.01530403,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02218922450996746,"score_gpt":0.2557066031132377,"score_spread":0.2335173786032702,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}